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ERCC4 is an essential human gene in the nucleotide excision repair (NER) pathway, which is responsible for
removing UV-C photoproducts and bulky adducts from DNA. Among the NER genes, ERCC4 and ERCC1 are
also uniquely involved in removing DNA interstrand cross-linking damage. The ERCC1-ERCC4 heterodimer,
like the homologous Rad10-Rad1 complex, was recently found to possess an endonucleolytic activity that
incises on the 5* side of damage. The ERCC4 gene, assigned to chromosome 16p13.1-p13.2, was previously
isolated by using a chromosome 16 cosmid library. It corrects the defect in Chinese hamster ovary (CHO)
mutants of NER complementation group 4 and is implicated in complementation group F of the human
disorder xeroderma pigmentosum. We describe the ERCC4 gene structure and functional cDNA sequence
encoding a 916-amino-acid protein (104 kDa), which has substantial homology with the eukaryotic DNA repair
and recombination proteins MEI-9 (Drosophila melanogaster), Rad16 (Schizosaccharomyces pombe), and Rad1
(Saccharomyces cerevisiae). ERCC4 cDNA efficiently corrected mutants in rodent NER complementation groups
4 and 11, showing the equivalence of these groups, and ERCC4 protein levels were reduced in mutants of both
groups. In cells of an XP-F patient, the ERCC4 protein level was reduced to less than 5%, consistent with XPF
being the ERCC4 gene. The considerable identity (40%) between ERCC4 and MEI-9 suggests a possible
involvement of ERCC4 in meiosis. In baboon tissues, ERCC4 was expressed weakly and was not significantly
higher in testis than in nonmeiotic tissues.
Nucleotide excision repair (NER) is a universal DNA repair
pathway that acts on most bulky chemical adducts and the
major photoproducts (cyclobutane and [6-4] pyrimidine
dimers) produced by UV radiation (19, 25, 52, 68). In xero-
derma pigmentosum (XP) patients, who have a very high risk
of skin cancer due to solar exposure, there is a partial or
complete deficiency in NER (15). This observation provided a
critical link between deficiency of an error-free repair process
and enhanced mutagenesis and carcinogenesis in humans (15,
37). Genetic analysis of XP cell lines identified seven comple-
mentation groups of incision-defective XP patients (30, 79)
and a common variant form of XP that is excision proficient
(14). Parallel studies with rodent cell mutants isolated in cul-
ture demonstrated 11 complementation groups that are phe-
notypically similar to the XP lines (51). The rodent mutants
proved well suited for cloning NER genes on the basis of
functional complementation because of efficient DNA trans-
formation (74, 76, 81, 83), and considerable overlap was found
between the XP and rodent groups (68). Thus, the genes XPA
(66), XPB (ERCC3) (83), XPC (34), XPD (ERCC2) (18, 81),
and XPG (ERCC5) (36, 57) have been characterized, as has the
ERCC1 NER gene (76), which is not involved in any known
human disorder (77).
Recently the NER process has been reconstituted by using
recombinant proteins and highly purified factors (1, 43, 44).
With the reconstituted systems, insights into the biochemical
mechanism of NER have been obtained. Damage recognition
likely involves XPA (2, 29), replication protein RPA (10, 24),
and possibly other proteins. The biochemical overlap between
transcription and NER is embodied in the transcription initi-
ation factor TFIIH, which contains the XPB 39-to-59 helicase
(16, 56) and the XPD 59-to-39 helicase (16, 55) as well as
approximately six other proteins (17). These helicase activities
are thought to participate in creating a preincision complex
that contains a single-stranded region encompassing the DNA
lesion. Asymmetrical dual incisions are made (27), first on the
39 side of damage by the XPG endonuclease (45) and then on
the 59 side by the ERCC1-ERCC4 endonuclease (40, 41, 43).
In the yeast Saccharomyces cerevisiae, the 59 incision is per-
formed by the homologous Rad10-Rad1 endonuclease com-
plex (5). Following the excision of oligonucleotides predomi-
nantly 27 to 29 bases in length (27, 43, 65), synthesis and
ligation complete the repair process (61).
Of the genes that are essential for the excision step of NER
in the reconstituted systems (other than those encoding certain
components of the TFIIH complex), all have been character-
ized at the level of the cDNA except for ERCC4. The human
ERCC4 genomic sequence was previously cloned by functional
complementation by transfection of a chromosome-specific
cosmid library (70). In this article we report characterization of
the gene and functional ERCC4 cDNA sequences, which cor-
rect the UV sensitivity of the CHOmutant UVS1 (22) assigned
to group 11 (51) as well as that of the prototype mutant
(UV41) in group 4 (71). These results imply that the two
groups are genetically equivalent. Our results also support the
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conclusion that ERCC4 is equivalent to XPF, on the basis of
biochemical complementation studies (47, 49) and microinjec-
tion experiments combined with sequence analysis (62).
MATERIALS AND METHODS
Cells and culture conditions. CHO cell lines AA8 (wild type), UV41 (NER
group 4), UV135 (group 5), UVS1 (group 11) (22, 51), and transformants were
grown at 378C in suspension or monolayer culture in a-modified minimum
essential medium with 10% fetal bovine serum and antibiotics, without selection
agents, as described previously (81). Population doubling times were determined
in exponential growth by counting concentrations of cell suspension on a Coulter
Multisizer II counter (Coulter Corporation). HeLa S3 and mouse L60WT4 cells
were grown in suspension culture under conditions used for CHO cells. Human
diploid fibroblasts XP3YO (XP-F, GM03542), immortalized XP2YOSV (XP-F,
GM08437A), and WI38VA13 (simian virus 40 immortalized WI38) cells were
maintained in monolayer culture in 15 to 20% fetal bovine serum.
cDNA library screening. A HeLa cDNA library in vector pEBS7 (48) was
screened under conditions reported earlier (69). Replicates of 14 filters, each
with 1.2 3 105 cells, were hybridized with ;18 kb of DNA derived from ERCC4
cosmid clone pER4-5 (70). Repetitive elements were blocked by an initial asso-
ciation between 1 mg of sonicated human placental DNA and 10 to 100 ng of
genomic probe, and hybridized filters were rinsed at 668C to a final stringency of
0.13 SSC (13 SSC is 0.15 M NaCl plus 0.15 M sodium citrate).
cDNA extension and construction of expression plasmids. To retrieve missing
cDNA sequences, gene-specific PCR primers were derived from library clone
sequences and used in reverse-transcribed PCR (RT-PCR) amplification of
HeLa poly(A)1RNA (20). PCR amplifications were conducted with high-fidelity
DNA polymerase PfuI (Stratagene) for 20 to 30 cycles at temperatures ;58C
above primer-annealing temperatures. Primary products were expanded by using
nested gene-specific and anchoring oligonucleotides in secondary and tertiary
amplifications of 20 to 30 cycles. Products generated from cosmid pER4-6 (70)
were obtained by a single course of 20 to 30 cycles. Intermediate and final
constructs of the ERCC4 cDNA were assembled in mammalian expression vector
pcDNA3 (Invitrogen) containing a human cytomegalovirus (CMV) promoter,
bovine growth hormone polyadenylation signal, and a neo gene for Geneticin
selection. Sequence determination of cDNA fragments and full-length construct
cER4-40, each subcloned into pBluescript II KS1 (Stratagene), was performed
by methods described below for cosmid sequencing.
Northern (RNA) blot analysis. A human and mouse RNA blot was generated
as described earlier (69). Poly(A)1 RNAs from HeLa S3 and mouse L60WT4
cells were electrophoresed on a 1% agarose–2.2 M formaldehyde gel, hybridized
with a 1.5-kb mid-ERCC4 cDNA PCR fragment, and rinsed with 23 SSC–1%
sodium dodecyl sulfate (SDS) at 608C. Baboon tissue poly(A)1 RNAs were
isolated from a 14-year-old male and separated on a 1% agarose–2.2 M form-
aldehyde gel as described previously (80, 87). The blot was probed first with a
1.4-kb SacII-EcoRV ERCC4 cDNA fragment and rinsed at 558C to a final
stringency of 0.13 SSC in 0.1% SDS. After removal of ERCC4 sequences, the
blot was probed with abundantly expressed glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) by using a 0.8-kb PstI-XbaI fragment of cDNA insert from
vector pHcGAP (American Type Culture Collection).
Transfection and transformant selection. After electroporation of lines UV41
and UVS1 at 300 V/1,600 mF with 5 mg of DNA in a volume of 1 ml, cultures
were grown for 28 to 44 h for expression and plated in 20 nM mitomycin (UV41
only) or were given 5 to 7 J of UV-C per m2 and then grown in 1.7 mg of
Geneticin (Gibco BRL Life Technologies) per ml. Ten UV41-derived transfor-
mant colonies (41.cER4.30 through -34 and 41.cER4.40 through -44) and three
UVS1-derived transformants (UVS1.cER4.1, -2, and -3) were isolated and grown
to mass culture. For UV survival measurements, three 10-cm-diameter dishes
were exposed at each fluence (71).
The XP lines XP3YO and XP2YOSV were electroporated at 0.3 3 107 to
1.03 107 cells per ml with 6 to 10 mg of linearized or supercoiled DNA. For assay
of expression of stably integrated DNA, XP2YOSV cells were grown for 48 h and
then plated at 0.83 105 or 83 105/100-mm-diameter dish in 0.8 mg of Geneticin
per ml. Eight to 10 days after electroporation, surviving cells received 10 J of
UV-C light per m2, and seven colonies surviving double selection were isolated
after an additional 7 days of growth. For assay of transient gene expression,
electroporated XP cells were grown for 16 h and then trypsinized and plated into
6-well trays at 1 3 105 to 2 3 105 cells per well and irradiated after 2 h of
incubation for attachment. Growth continued for 4 to 21 days, depending on UV
fluence and cell line.
Excision nuclease assay. Cell extracts (38), excision substrate preparation (40),
and repair assay conditions (46) were described earlier. An aliquot of 50 mg of
cell extract (or 25 mg each for a mixture) was incubated for 60 min at 308C with
6 fmol of substrate DNA, a double-stranded 140-mer containing a centrally
positioned cholesterol adduct and a 32P label at the sixth phosphodiester bond 59
to the adduct. Products were resolved on a 10% denaturing polyacrylamide gel
and, after autoradiography, excision products were quantified by scanning dried
gels with an AMBIS Systems Scanner.
Immunoblot analysis. To produce anti-ERCC4 antibody, an N-terminal 260-
amino-acid (aa) polypeptide of ERCC4 was overexpressed in bacteria by using
an NcoI-BamHI fragment of the ERCC4 cDNA inserted into the same sites in
the polylinker of the pET26b expression plasmid (Novagen). After induction
using isopropyl-1-thio-b-D-galactopyranoside, cells were lysed, and protein was
purified in 0.05% Sarkosyl on a column of Ni-nitrilotriacetic acid agarose (Qia-
gen). Mouse antiserum was raised against this antigen, and ascites fluid was used
for the final collection of polyclonal antibody. Extracts from cell lines were
prepared either by sonication of harvested cells in 50 mM Tris (pH 8.0)–1 mM
EDTA–1 mM dithiothreitol–10% glycerol or by methods earlier described (38).
Protein samples of 50 mg were electrophoresed in a 7.5% SDS-polyacrylamide
gel, transferred to nitrocellulose membrane, and probed with anti-ERCC4 anti-
body by the enhanced chemiluminescence detection method as described by the
manufacturer (Amersham).
Cosmid subcloning and sequencing. Human cosmid pER4-6 containing the
ERCC4 gene was sonicated, end repaired with Klenow and T4 polymerases, size
selected, and cloned into M13mp18 as described earlier (32, 39). DNA templates
were prepared using 96-well-format M13 kits (Qiagen). Single-stranded tem-
plates were sequenced on a Catalyst 800 Molecular Biology Labstation (Applied
Biosystems Division [ABD]; Perkin Elmer) by using a fluorescently labeled
universal 221m13 primer and Taq cycle sequencing (ABD). The resulting se-
quencing ladders were loaded onto 4.75% polyacrylamide gels, and data were
collected on ABD 373A DNA Sequencers. Vector, ambiguous sequences, and
clones containing Alu repetitive elements were identified prior to assembly by
using a prescreening feature of the GENeration sequence assembly package
(IntelliGenetics). Ambiguities in the assembled sequence were resolved by visual
inspection of the chromatograms or resequencing with Sequenase Dye Deoxy
Terminators (ABD). Areas containing compressions or other mobility artifacts
were resequenced by using Taq Dye Deoxy Terminators with dITP. Cosmid
pER4-6 sequence was obtained at a level of sevenfold redundancy and 90%
coverage of both strands. PCR primers designed from cosmid sequences specif-
ically for validation were tested with cosmid and human genomic DNA to verify
the presence of a fragment of a predicted size in the human genome. Of 21
primer pairs tested, 14 gave products with both the cosmid and human genomic
DNA, 5 gave a product with only the cosmid genomic DNA, and 2 gave no
products. The last results most likely represent complications of the PCR rather
than inaccurate sequence.
Sequence homology analysis. The intron-exon structure of ERCC4 was deter-
mined by comparison of cDNA sequences with the genomic sequence by using
ALIGN (IntelliGenetics) and assessment of the coding region predictions made
by XGRAIL versions 1.2 and 1.3 (75). By using ALIGN, repetitive elements were
identified by comparison to a subset of known human repeats: Alu, L1, transpo-
son-like human element, and long terminal repeat. Additional searches were
performed against the Genome Sequence Data Base (GSDB) (daily update),
dbEST (daily update), and SWISSPROT (release 32; December 1995). Protein
alignment was generated by GeneWorks software (IntelliGenetics).
Nucleotide sequence accession numbers.GSDB designations: cosmid pER4-6,
L76568; cDNA cER4-40, L77890.
RESULTS
Construction of functional ERCC4 cDNAs. Initially, a HeLa
cell cDNA expression library in vector pEBS7 was screened by
using a mixture of EcoRI fragments of a functional cosmid,
pER4-5. Three of five positive clones (cER4-1, cER4-4, and
cER4-5, with 0.7- to ;2-kb inserts) were electroporated into
UV41 cells, but none conferred UV resistance. Nucleotide
sequences subsequently derived for the five clones confirmed
their identity with ERCC4 by alignment with sequences from
cosmid pER4-6 (70). All clones were found to carry consider-
able intronic material in addition to various lengths of coding
sequence. Clones cER4-4 and cER4-5 overlapped and pro-
vided 1,795 bp of ERCC4 open reading frame (ORF) repre-
senting the 59 half of the coding region, and clone cER4-2
contained 354 bp of the final third of the ORF (Fig. 1). Using
cDNA-derived sequences, RT-PCR was used to amplify miss-
ing 59-end, middle, and 39-end regions. Subcloned 59-end RT-
PCR products obtained from HeLa cell cDNA extended only
12 bp upstream from the first of two closely spaced in-frame
ATG codons; the downstream ATG was present in clone
cER4-5. Surprisingly, subcloning of the major 39 RT-PCR
product generated two distinct species. Eleven of 14 subclones
had a splicing variation, which is shown as clone cER4-22 (Fig.
1), which terminated the ORF in exon 11 at position 3180 (see
Fig. 6). However, three clones, represented by cER4-40 in Fig.
1, were not spliced. They extended beyond the splice donor site
to the poly(A) region, with an ORF ending at position 2749.
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Constructs cER4-22 (spliced) and cER4-34 and cER4-40 (un-
spliced) were assembled in the pcDNA3 CMV expression vec-
tor from a combination of library and PCR-derived sequences.
To test for the minimum functional transcript, clone
cER4-34 was constructed by using only 30 bp downstream of
the stop codon. Both cER4-34 and cER4-40 have the same
2.75-kb ORF, which conferred UV resistance to the group 4
mutant UV41 (see below). Clone cER4-22, with a 2.58-kb
ORF representing the predominantly amplified transcript, was
not functional. A Northern blot of human and mouse poly(A)1
RNA, hybridized with a 1.5-kb mid-cDNA PCR fragment, had
a major band of ;3.8 kb in both species, slightly smaller in the
mouse RNA (Fig. 2). A transcript of that length is consistent
with the ;3,850-bp construct cER4-40. Two additional frag-
ments of ;7 and 2.4 kb, seen predominantly in human RNA,
likely resulted from improperly processed or alternatively
polyadenylated transcripts.
Correction of UV sensitivity in CHO transformants. The
functionality of plasmids cER4-34 and cER4-40 was measured
in stable transformants of UV41 in response to UV irradiation.
Transformants 41cER4.34 and 41cER4.40 showed ;90% res-
toration of UV resistance compared with wild-type AA8
(based on D10, the UV fluence reducing survival to 10%) (Fig.
3). In addition, the transformants had significantly enhanced
growth rates. During 5 weeks of exponential growth in suspen-
sion culture, the doubling times of the two transformants were
13.3 to 13.4 6 0.17 h (standard error of the mean) compared
to 14.1 6 0.14 h for UV41 and 12.8 6 0.22 h for AA8 cells,
representing a 54% increase toward the wild-type growth rate.
ERCC4 cDNAs were also transferred into cell line UVS1,
which was previously assigned to complementation group 11
(22, 51). ERCC4 and control transformants of UVS1 were
generated, and their UV sensitivity was found to be fully cor-
rected compared with that of wild type AA8 cells (Fig. 3). This
result implies identity between complementation groups 4 and
11, and this was confirmed in excision nuclease assays in which
UVS1 was complemented by purified ERCC1-ERCC4 com-
plex (6). However, UV resistance was not transferred to UVS1
cells by transfection with genomic ERCC4 clone pER4-6 under
selection for both UV resistance and neo expression (results
not shown). Thus, correction of UVS1 by the human ERCC4
cDNAmay require overexpression from the CMV promoter to
overcome the effects of a possible dominant negative mutation.
Restoration of excision nuclease activity in CHO transfor-
mants. To confirm that the nearly normal UV sensitivity and
growth rate of the UV41 transformants resulted from en-
hanced DNA repair, we analyzed transformants using a cell-
free assay for damage excision activity. Figure 4A shows an
FIG. 1. Construction of ERCC4 cDNAs. cER4-40 and cER4-34 represent two functional cDNA clones, constructed as composites from cER4-22 (mRNA leader
sequence to SfuI) and cosmid pER4-6 (SfuI to bp 31368), in expression vector pcDNA3 (Invitrogen). Clone cER4-22 is an alternatively spliced, nonfunctional variant
assembled from library clones cER4-4 and cER4-5 and RT-PCR fragments.
FIG. 2. Northern blot analysis of ERCC4 poly(A)1 RNA. (A) Human
(HeLa) and mouse (L60WT4) RNA. The blot was hybridized with a 1.5-kb PCR
fragment from the middle region of ERCC4 cDNA. Lane 1, 10 mg of total human
RNA; lane 2, 5 mg of human poly(A)1 RNA; lane 3, 5 mg of mouse poly(A)1
RNA. Arrow indicates a 3.8-kb band hybridizing in both human and mouse
RNA. (B) Baboon tissue RNA. Ten micrograms of poly(A)1 RNA from baboon
tissues was hybridized first with a 1.4-kb SacII-EcoRV ERCC4 cDNA fragment
and then with a probe for GAPDH. Lane 1, testis; lane 2, spleen; lane 3, lymph
node; lane 4, lung; lane 5, liver; lane 6, kidney; lane 7, heart; lane 8, brain.
Markers indicate 4.4 and 1.6-kb bands appearing in all tissues. ERCC4 and
GAPDH hybridizing bands were quantified with Molecular Analyst version 1.4
software on a Molecular Imager (BioRad), and the ratio of 4.4-kb band values to
GAPDH band values was calculated for each tissue. Comparative levels of
expressed ERCC4 (individual tissue ratios normalized to the testis ratio) are
shown below the ERCC4 lanes. Photographs of ERCC4 hybridization images and
the GAPDH autoradiogram were scanned and processed with Adobe Photoshop
3.0 software.
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autoradiogram comparing the excision products (24- to 32-
nucleotide [nt] fragments released from a 140-bp adducted
substrate) of wild-type, mutant, and transformant cell extracts.
Combined extracts of group 5 mutant UV135 and UV41 (lane
4) served as a positive control, to demonstrate the level of
activity obtainable with complementing extracts. No detectable
product was released by either mutant line (UV41 and UV135
in lanes 2 and 3, respectively), but excision products were
generated by the transformant extracts (lanes 5 and 7). The
absolute levels of excision are summarized in Fig. 4B. Wild-
type AA8 and the complementing mutant extracts (Fig. 4B,
UV41 1 UV135) had similar excision activities. In the trans-
formants, the activity was restored to ;15 to 20% that of the
wild type. However, complementation of the transformant ex-
tracts with UV135 did not reach the excision level observed in
the UV41 1 UV135 control, an effect attributable to variation
in the quality of the extract preparations. With this effect taken
into account, excision in the transformants can be normalized
to ;20 to 40% that of the wild type.
ERCC4 gene structure. The complete sequence was deter-
mined for cosmid pER4-6 (Fig. 1). Comparison of cosmid and
cDNA sequences showed that the gene is composed of 11
exons and spans a genomic distance of 28.2 kb (Fig. 5). No
polymorphic differences were observed between the cDNA
and cosmid sequences, which were derived from different
sources. A composite nucleotide sequence showing the cDNA
and flanking genomic regions is depicted in Fig. 6. Promoter
consensus elements such as TATA, CAAT, and GC boxes are
absent, and the 39 untranslated region (UTR) has no AAT
AAA polyadenylation signal (see Fig. 6 legend). The region
beginning 275 bp upstream of the translation start site is rich in
recurring elements. In particular, the heptamer TTCGGC(T
/C) is repeated 10-fold. The 39 UTR contains a 93-bp dyad
repeat with 89% identity (positions 2937 to 3029 and 3045 to
3137), which may have functional significance. Two candidate
ATG translation start codons, separated by 30 nt, are present.
Although the downstream ATG, with a purine at position 23,
more closely matches the optimal setting (31), sequences sur-
rounding both codons may provide an acceptable initiation
context, and our translation begins with the first ATG. The
polypeptide predicted by this sequence has 916 amino residues,
with a calculated Mr of 104,491 and pI of 6.49.
By the procedure for 59 rapid amplification of cDNA ends
(20), 59 poly(A)-tailed HeLa mRNAs were amplified between
poly(T)-anchoring primers and ERCC4-specific primers either
289 or 399 bp downstream of the first ATG. The resulting
single products were ;320 and ;425 bp, respectively, i.e., only
;10 to 30 bp longer than predicted for the coding sequence
alone. Four subcloned 59 products of rapid amplification of
cDNA ends had 59-ward sequences beginning at positions 212
(Fig. 6) to 122. RT-PCR amplification of the region between
positions 287 and 1289 failed to generate a product, arguing
that the ERCC4 transcript does not extend that far upstream
and that the leader sequence is short.
ERCC4-related proteins. The conceptual translation of the
ERCC4ORF gives a protein of 916 aa (Fig. 6). ERCC4 protein
exhibits notable homology with S. cerevisiae Rad1 (50), S.
FIG. 3. UV-C survival curves of NER group 4 and 11 ERCC4 transformants.
One experiment is shown for AA8, UV41, and transformants 41.cER4.34 and
41.cER4.40. Error bars for UVS1 curves show the standard deviations of mea-
surements for two Geneticin-resistant vector transformants and three ERCC4
transformants (UVS1.cER4).
FIG. 4. Excision activity of UV41 transformants. (A) Excision assay autora-
diogram. The prominent ;28-nt excision product and unexcised 140-mer sub-
strate are indicated. Lanes 1 to 3, control cell lines; lanes 5 and 7, transformants;
lane 4, UV41 mixed with UV135, showing complementation of the repair defect;
lanes 6 and 8, transformants mixed with UV135. (B) Quantitation of correction
in ERCC4 transformants shown in panel A. Excision is expressed as percent
substrate released. Error bars are standard errors of the means for duplicate
experiments with AA8, 41cER4.34 (4.34), and 41cER4.40 (4.40).
FIG. 5. Intron and exon structure of the human ERCC4 gene region. Se-
quence of cosmid pER4-6 was generated from a total of 585 M13mp18 subclones
spanning 35.6 kb. In addition to the ERCC4 coding region, nine Alu family
repeats (0.25 Alu per kbp) were identified. Also, two genes, a ribosomal gene and
a zinc finger gene, were located on the inverse strand.
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pombeRad16 (13), and DrosophilaMEI-9 (60), all of which are
implicated in NER (Fig. 7). The Rad1 protein is 184 aa longer
than ERCC4, and for optimum alignment we removed the
Rad1 N- and C-terminal regions. Overall identity of ERCC4
with Rad1 is 28% (51% similarity); identity is 33% with Rad16
(57% similarity) and 40% (61% similarity) with MEI-9. In the
middle region of ;250 aa (not shown in Fig. 7), ERCC4 is not
conserved. The degree of homology is highest for ERCC4
residues 16 to 304 and 570 to 830, suggesting that the protein
consists of at least two functional domains. In the N-terminal
region, ERCC4 has two consensus leucine zippers (33), which
might promote interaction with other proteins.
Expression of ERCC4 cDNAs in XPF cells.We attempted to
demonstrate functionality of the ERCC4 cDNA constructs in
cells of the XP2YO lineage (23, 85), the only lines of the XP-F
complementation group that were available to us. We found
that immortalized XP2YOSV (GM8437A) cells, which are
only ;two- to threefold sensitive to killing by UV-C, were also
exceptionally heterogeneous in UV sensitivity. Using a rela-
tively UV-sensitive subclone of XP2YOSV, we observed slight-
ly enhanced UV resistance from cER4-40 transfection in a
transient correction assay that measures cell growth (data not
shown). Surprisingly, confirmation of this result was prevented
by a sudden cessation of growth, a phenomenon seen with
FIG. 6. Composite of cDNA sequence, translated amino acid sequence, and flanking genomic regions. The ORF spans positions 1 to 2748. Sequences at positions
2300 to 213 and 3845 to end are from genomic cosmid pER4-6; positions 212 to 3844 are derived from poly(A)1 RNA. Two translation start codons (ATG) and the
stop codon (TGA) are marked in bold. In the promoter region, a core repeat, TTCGGC(T/C), is shown in bold. A 15-bp repeat is overlined, and a 17-bp repeat is
underscored. In the leader region at position 212 (G), the start position of the most 59-ward RT-PCR product is shown underlined and in a larger type size. Within
the ORF, a potential nuclear localization signal, KKKKRK (boxed, residues 486 to 491), is encoded from positions 1456 to 1473. In the 39 UTR, a 93-bp dyad repeat
is underlined, and two polyadenylation sites (CA) found in 39-end PCR products are shown underlined and in a larger type size. In the cloned 39 RT-PCR products,
polyadenylation began at positions 3813 and 3846. Although this region contains no consensus poly(A) signal, a 5.9-kb linear sequence (CMV promoter and cDNA
sequence extending to the SfuI site of cER4-22 [Fig. 1], joined with cosmid pER4-6 from SfuI to position 31760), which contained no other polyadenylation signals,
was functional upon transfection. Alternative splicing represented in cER4-22 is indicated by arrows at positions 2500 (splice donor), 3117 (splice acceptor), and 3181
(translation stop codon TAA).
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about 70% of the subclones. Transfections of XP2YOSV with
cER4-40 that was linearized by cutting within the vector se-
quence, which we expected to transfer both ERCC4 and the
linked neo gene, efficiently produced stable Geneticin-resistant
transformants at a frequency of ;1023. However, several Ge-
neticin-resistant clones initially surviving exposure to 10 J of
UV-C per m2 exhibited neither elevated UV resistance nor
excision activity nor increased ERCC4 protein levels (results
not shown). Transfection of diploid fibroblasts from the closely
related XP-F line XP3YO (GM3542) with cER4-40 and
cER4-34 also conferred no transient resistance to UV-C. This
behavior of the ERCC4 cDNAs suggests that expression may
be suppressed in the XP2YO lineage.
ERCC4 protein levels in human and CHO cells. To identify
the ERCC4 protein and evaluate its status in repair-proficient
and -deficient cells, immunoblot analysis was performed with
antibodies recognizing an N-terminal ERCC4 polypeptide. In
extracts from repair-competent HeLa and WI38VA13 cells, a
protein with a mass of ;110 kDa was detected; this value
correlates well with the calculated value of 104 kDa deduced
from the cDNA sequence (Fig. 8a). In immortalized XP-F
cells, this protein was present at a level less than 5% that in the
WI38VA13 cells (Fig. 8). Extracts from CHO mutants UV41
and UVS1 also showed reduced levels of ERCC4 compared
with that of AA8 (Fig. 8b). In the cDNA transformant,
41cER4-34 (lane 4), the expressed protein was detected at the
same position as the human control (lane 1), confirming that
construct cER4-34 has a full-length sequence. The intermedi-
ate level of ERCC4 expressed in the transformant (;40% of
wild-type AA8) suggests instability of human ERCC4 protein
in the hamster cells, an observation that is consistent with the
relatively low level of excision measured in cell extracts of this
transformant. Although significantly diminished, the amount
was sufficient to restore survival after UV-C almost completely.
Expression of ERCC4 mRNA in baboon tissue. To deter-
mine whether transcript regulation shows tissue-specific varia-
tion, we analyzed a panel of primate tissues for the level of
ERCC4 mRNA (Fig. 2B). Abundantly expressed GAPDH was
also measured to standardize the level of mRNA present in
each lane. All baboon tissues had two species,;4.4 and 1.6 kb,
while those in human RNA were ;3.8 and 2.4 kb. The differ-
ences in transcript lengths between human and baboon RNAs
may be a consequence of variability in untranslated regions of
the transcripts. A larger transcript (;7 kb), seen in human
RNA, had no apparent representation in baboon tissues and
only a minor presence in mouse RNA. Expression of ERCC4
was seen in all tissues, with levels in testis (lane 1) and brain
(lane 8) lower than those in spleen, lymph node, lung, liver,
kidney, and heart when normalized to GAPDH.
DISCUSSION
Starting with probes from the previously cloned ERCC4
genomic sequence, we have reconstructed a functional, com-
posite cDNA from a combination of cDNA library clones and
RT-PCR products derived from mRNA and cosmid genomic
sequences. The ORF encodes an ERCC4 protein of 916 aa;
comparative values are 1,100 aa for S. cerevisiae Rad1, 892 aa
for S. pombe Rad16, and 946 aa for Drosophila MEI-9. The
degree of conservation between ERCC4 and its homologs
ranges from 28% identity for Rad1 to 40% identity for MEI-9
(Fig. 7). Rad1 and Rad16 proteins are essential components of
FIG. 7. Alignment of conserved regions of the ERCC4 family of proteins, Drosophila MEI-9, S. pombe Rad16, and S. cerevisiae Rad1. ERCC4 protein sequence
was derived from the ORF of functional clones cER4-34 and cER4-40, which were confirmed by comparison with genomic sequence. Rad1 residues 1 to 69 and 1037
to 1100 were deleted for optimal alignment. Identical residues are shown in shaded boxes; conserved residues are shaded only. Two consensus leucine zipper regions
found in ERCC4 (at residues 233 to 254 and 270 to 298) are indicated by overlining, and the Rad10 binding domain of Rad1 is underscored.
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NER in yeasts (13, 50, 86), and MEI-9 is essential for efficient
meiotic recombination as well as NER (8, 12). mei-9 was first
identified in a screen for mutations causing meiotic nondis-
junction (3), and it is required for efficient reciprocal exchange
(12). Subsequently, mei-9 was identified as a gene involved in
mutagen sensitivity and excision repair (8). Thus, mei-9 differs
from RAD1, rad16, and other NER genes in yeasts, which have
not been found to have a role in meiosis. The relatively high
level of conservation between ERCC4 and MEI-9 suggested
the possibility that ERCC4 might be secondarily involved in
meiosis. Our examination of baboon tissues showed no eleva-
tion in whole testis compared with nonmeiotic tissues. How-
ever, the possibility remains that ERCC4 may have a recom-
bination function in meiotic cells.
The ERCC1-ERCC4 heterodimer purified from HeLa cells
(47) is the human homologous counterpart of the S. cerevisiae
Rad10-Rad1 endonuclease complex (64, 73), which had inci-
sion activity 59-ward of the lesion in NER, as inferred from
model substrates (5). The purified ERCC1-ERCC4 complex
had analogous incision activity (40, 41, 47) and promoted re-
pair in a highly purified reconstituted system (43). During
repair, the ERCC1-ERCC4-mediated 59 incision appears to
require prior 39 incision by the XPG endonuclease (40, 43, 45).
In Rad1, the region of interaction with Rad10 lies between
residues 809 and 997 (Fig. 7) (4), and dimeric association was
also demonstrated for the C terminus of Rad16 with Swi10, a
homolog of Rad10 (13). The substantial identity among
ERCC4 and its three homologs (52 of 188 residues; Fig. 7) in
this region suggests that it also contains the ERCC1 binding
domain in ERCC4. The nonfunctional cDNA construct
cER4-22 (Fig. 1) is expected to encode a truncated ERCC4
protein that diverges after aa 833 and is missing the 83 normal
C-terminal aa. This truncation overlaps with the region that
involves the Rad1-Rad10 interaction. In HeLa cells, a preva-
lent ERCC4 transcript corresponds to this truncated sequence,
but it is unclear whether the truncated protein of 856 aa has
physiological significance.
We found that ERCC4 cDNA efficiently corrected the CHO
UVS1 mutant (Fig. 3) that was assigned to complementation
group 11 (22, 51). Previously, a hypothetical ERCC11 protein
was postulated to reside within the ERCC1-ERCC4 complex,
on the basis of biochemical complementation studies (78).
Moreover, our previous attempt to correct UVS1 cells by
transfection with an ERCC4 cosmid that corrected the group 4
mutant UV41 gave no evidence for restoration of UV resis-
tance, which suggested that UVS1 represented a distinct gene.
From this result it would appear that UVS1 may contain a
mutant hamster ERCC4 allele that behaves in a codominant
manner in the presence of human ERCC4 and that is not
complemented by ERCC4 unless it is expressed by a strong
promoter. We have no explanation for the reported comple-
mentation between UVS1 and UV41 (22). Both UVS1 (22)
and the CHO mutant UV140 (11), which is also corrected by
ERCC4 cosmid pER4-6 (70), exhibit only weak sensitivity
(two- to threefold) to the cross-linking agent mitomycin, com-
pared to the 90-fold hypersensitivity of the prototype mutants
in groups 1 and 4 (26). UV140 and UVS1 are ;fourfold sen-
sitive to killing by UV-C (11, 22). This differential hypersensi-
tivity to UV-C versus mitomycin between the mutants suggests
either that different functional domains of ERCC4 are in-
volved in UV-C versus cross-link repair or that cross-link re-
pair has less stringent requirements for the level of ERCC4
activity. CHO group 1 mutants that are relatively resistant to
mitomycin have also been identified (11).
UV41 cells were corrected, to various degrees, by transfec-
tion with either cDNA construct cER4-34 (having a truncated
39UTR) or cER4-40 (representing the native mRNA) (Fig. 1).
Incomplete correction was seen with all endpoints for the two
transformants. (i) Population doubling times in culture were
shortened significantly. This effect in UV41 might be due to the
restoration of NER capacity through its action on spontaneous
damage, such as oxidative lesions (53). Unrepaired oxidative
damage leading to disruption of the normal cell cycle regula-
tion and p53 response was invoked to explain the severe ab-
normalities in and early death of ERCC1 knockout mice, which
have abnormal p53 expression (42). Alternatively, ERCC4 may
have a role in cell cycle progression that does involve repair.
(ii) Cell survival after UV-C exposure gave an ;90% level of
correction based on D10 fluences (Fig. 3), which was a signif-
icant improvement over the 30 to 64% level of correction seen
earlier with the ERCC4 genomic sequence (70). These partial
corrections presumably reflect the inefficient functioning of
human ERCC4 protein complexed with hamster ERCC1. Con-
sistent with this idea is the finding that overexpression of hu-
man ERCC1 in wild-type AA8 cells conferred increased sen-
FIG. 8. Immunoblot analysis of cell extracts using anti-ERCC4 antibody. (a)
Detection and estimation of molecular mass of the ERCC4 protein. Lane 1,
HeLa S3; lane 2, WI38VA13; lane 3, XP-F (XP2YOSV). The arrow indicates the
full-length ERCC4 protein with a mass estimated at 110 kDa; asterisks are
adjacent to ERCC4 degradation products or cross-reacting proteins. Molecular
masses of protein standards are indicated to the left of the image. (b) Detection
and quantitation of ERCC4 protein in mutant cell lines. After the film was
developed, the immunoblot image was captured using a video camera linked to
the NIH-Image software program (version 1.58) run on an Apple Quadra 650
computer. The integrated optical density for each band at the 110-kDa position
was subsequently determined with the RFLPscan program (version 2.01; Scana-
lytics, CSP Inc.). The values, normalized to that of human WI38VA13, are
relative and are the standard errors of the means from four experiments. Lanes
are identified at the bottom of the panel; lane 4, cER4T, is transformant
41cER4.34. For data presentation, the immunoblot was scanned and processed
with Adobe Photoshop 3.0 software.
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sitivity to cross-linking agents (9). (iii) Excision nuclease
activity, which was undetectable in UV41 extracts, was present
in transformants at,40% of the AA8 level (Fig. 4), suggesting
that the heterologous human protein may function even less
efficiently in vitro than in vivo. A similar partial level of cor-
rection was seen in excision nuclease assays with ERCC4
genomic transformants (70). (iv) The hamster ERCC4 protein
level in UV41 was very low, while the transformants had total
ERCC4 levels that were ;40% of the AA8 level, or lower if
the antibody recognized human ERCC4 more efficiently than
hamster ERCC4 (Fig. 8 and results not shown). ERCC4 ap-
pears to be unstable in hamster cells in the absence of over-
expressed ERCC1.
It was previously suggested on the basis of biochemical
complementation studies that ERCC4 might be equivalent to
XPF (7, 49, 78). The purified complex containing ERCC1 and
the 112-kDa protein was shown to complement UV41 and
XP-F cell extracts (47). More recently, anti-ERCC4 antibody
detected the 112-kDa protein that copurifies with ERCC1, and
recombinant ERCC1-ERCC4 complex isolated from the bac-
ulovirus system corrected the repair deficiency in XP-F cells
using the excision nuclease assay (6). In the latter assay, the
ERCC4 protein was encoded by the sequence from cDNA
plasmid cER4-34 (Fig. 1). Mutations were also identified in
ERCC4 in XP-F cells, providing genetic evidence that ERCC4
equals XPF (62).
Using our cDNA constructs, we were unable to convincingly
demonstrate correction of the related XP-F cell lines
XP2YOSV and XP3YO in both transient and stable transfec-
tions. We attribute these negative results in part to the rela-
tively mild UV-C sensitivity and partial repair capacity (21) of
the immortalized XP-F cells combined with unpredictable
growth upon subcloning and also to an apparent lack of stable
expression of the ERCC4 cDNA. The latter inference is sug-
gested by the uncorrected UV sensitivity of six stable neo
transformants of XP2YOSV resulting from cER4-40 transfec-
tion. Joint integration and coexpression of neo and ERCC4
were expected for at least some transformants using linearized
molecules. The failure of the overexpressing ERCC4 cDNA to
confer UV resistance was consistent with results of our attempt
to transfer the ERCC4 gene using cosmid pER4-7, which also
gave no clear correction of Geneticin-resistant XP2YOSV
cells. Thus, ERCC4 expression controlled either by the CMV
promoter or by its native promoter did not restore repair
capability. Aberrant XP-F regulation or a dominant negative
effect of a mutant allele might block expression of ERCC4
transgenes in cells of the XP2YO lineage.
In an earlier study, somatic cell hybrids between diploid
XP3YO and UV41 cells were produced by selecting for
complementation of mitomycin sensitivity (72). Since signifi-
cant restoration of both mitomycin and UV resistance was
observed, it was concluded that the UV41 and XP-F mutations
were in different genes. However, in retrospect we realize this
interpretation was incorrect, since the results can be explained
by the partial repair capacity of the XP-F mutant allele(s) (21).
In a study involving microcell-mediated chromosome transfer,
it was concluded that human chromosome 15 gave partial
correction to UV resistance in XP2YOSV cells (54). This con-
clusion is at odds with the localization of ERCC4 to chromo-
some 16p13.13-p13.2 (35) and can be attributed to the extreme
population heterogeneity we observed for UV sensitivity with
XP2YOSV.
Among the NER genes, ERCC1 and ERCC4 are uniquely
involved in interstrand cross-link repair, as evidenced by the
extreme sensitivity of a subset of the CHO mutants in groups
1 and 4 to cross-linking agents (26, 63, 84). Mutants in NER
groups 2, 3, and 5 are apparently relatively proficient in cross-
link repair (but not the repair of monoadducts accompanying
cross-links), since they are much less sensitive to cross-linking
agents. Thus, ERCC1 and ERCC4 proteins must possess a
function, which is likely involved in homologous recombina-
tion, that assists in removing cross-links. A unique role for the
Rad10 and Rad1 proteins in mitotic recombination (28, 58, 59)
parallels the putatively unique roles of ERCC1 and ERCC4 in
cross-link repair (see Discussion in reference 67). The cloned
ERCC4 cDNA and recombinant protein should help to eluci-
date ERCC4’s putative recombinational repair function as well
as help with further investigation into its possible role in re-
combination during meiosis.
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ADDENDUM IN PROOF
Fresh preparations of baboon poly(A)1 RNA and human
ERCC4 cDNA probe were made and used in two additional
Northern blots like those shown in Fig. 2B. In these new
long-exposure blots, 7.5-kb hybridizing bands were detected in
all of the tissues, which included ovary tissue; however, the
7.5-kb band was slightly more abundant in the lane containing
RNA from testes. In addition, hybridizing bands of 4.4, 3.7
(most intense), and 2.0 kb were detected only in the testes.
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